Tocqueville Asset Management L.P. Takes $843,000 Position in Corteva, Inc. $CTVA

Tocqueville Asset Management L.P. purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 9,955 shares of the company’s stock, valued at approximately $843,000.

Several other institutional investors and hedge funds have also bought and sold shares of CTVA. JPL Wealth Management LLC bought a new position in shares of Corteva in the 3rd quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva during the fourth quarter valued at approximately $27,000. Bank of Jackson Hole Trust bought a new stake in shares of Corteva during the fourth quarter valued at approximately $28,000. Cornerstone Financial Management LLC purchased a new stake in Corteva in the fourth quarter worth $29,000. Finally, Elevation Wealth Partners LLC raised its holdings in Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after purchasing an additional 261 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Stock Performance

Shares of CTVA stock opened at $79.46 on Friday. The company has a market capitalization of $53.02 billion, a price-to-earnings ratio of 52.62, a price-to-earnings-growth ratio of 2.41 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The company’s 50-day moving average is $82.01 and its 200 day moving average is $80.20.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the prior year, the firm posted $2.20 earnings per share. The business’s revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Analyst Ratings Changes

Several brokerages have commented on CTVA. Weiss Ratings lowered Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Bank of America increased their price target on shares of Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Barclays lifted their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. BNP Paribas Exane upped their price objective on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Finally, BMO Capital Markets raised their target price on shares of Corteva from $95.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.